Researchers at the Universities of Bonn and Regensburg have elucidated the structure of a central cellular inflammatory switch. Their work shows which site of the giant protein called NLRP3 inhibitors can bind to. This opens the way to develop new pharmaceuticals that could target inflammat ... more
Prof. Dr. Jörg Heilmann
Universität Regensburg, Lehrstuhl für Pharmazeutische Biologie
born 1966, studied pharmacy at the Heinrich-Heine-University Düsseldorf and received his licence to practise in 1991. From 1991 – 1992, he worked as a pharmacist in the Löwen-Apotheke in Mülheim an der Ruhr. After receiving his doctorate in 1997 from the Chair in Pharmaceutical Biology at the Heinrich-Heine-University Düsseldorf, he occupied a post-doctoral position in the working group of Prof. Dr. R. Bauer. He completed his habilitation (pre-professorship) at the Swiss Federal Institute of Technology in Zurich (Mentor: Prof. Dr. Otto Sticher), and in 2003, was named a lecturer. In 2004, he was offered the position of “C4” Professor for pharmaceutical biology at the University of Regensburg. His research focuses on ethno-pharmaceutical questions, the search for lead structures in plants, development of in vitro test systems, ecologically important secondary substances of plant origin, analysis and quality control of herbal medicinal products, metabolism of flavonoids, synthesis of phenolic compounds and their metabolites.